XRCC1 and breast cancer: Our results agree with previous studies reporting XRCC1399Arg associated with lower levels of bulky DNA adducts [30], [31], due to higher DNA repair activity [32], and with two recent meta-analyses where XRCC1 Arg399Gln polymorphism was not related to BC risk [33], [34].